Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
AOD-9604 structure

AOD-9604

Metabolic
Phase 1 Research
35%
Low Risk
1/5

Dosing Protocol

Typical Dose 300 mcg
Range 250 - 500 mcg
Maintenance 300 mcg daily

Pharmacokinetics

Half-Life 2.5 hrs
Onset 30 min
Peak 1.5 hrs
Duration 6.0 hrs
Bioavailability 90%
Primary Route Subcutaneous

Administration

Routes Subcutaneous, Oral
Injection Sites Abdomen
Needle Gauge 29-31G
Syringe Type Insulin
Timing Fasted, Morning

Reconstitution

Diluent Bacteriostatic Water
Volume 2 mL
Concentration 2500 mcg/mL
Stability 21 days refrigerated
Vial Sizes 5 mg

Special Instructions

Best taken fasted, 30 min before breakfast. Inject into abdominal fat for localized lipolysis effect.